4.2 Hormonal medical treatments Hormonal medical treatments for endometriosis-associated infertility target the endocrine pathogenetic mechanisms of the disease, aiming to block menstruation through inhibition of the hypothalamus-pituitary-ovary (HPO) axis or induction of pseudodecidualization with consequent amenorrhea, thereby impairing the progression of endometriotic implants ( GnRH agonists (goserelin, leuprolide, nafarelin, buserelin, triptorelin) downregulate pituitary GnRH receptors, leading to hypoestrogenism and amenorrhea, which results in regression of endometriotic lesions and improvement in pain symptoms
It is a chelated form bound to glycine for steady uptake without an osmotic pull
This stack has gained significant attention in research communities because it addresses a frustrating reality: standard weight loss often reduces subcutaneous fat (the pinchable fat under your skin) while leaving visceral fat largely intact
BPC-157, derived from human gastric protein, is marketed for gut healing, tendon repair, and injury recovery